Ophthotech
| Region | Nordamerika |
| ISIN | US6837451037 |
| Sektor | Biotechnologie |
| Website | http://www.ophthotech.com/ |
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases.
| Titel | Datum |
|---|---|
| MISC Should Ease Into 2026 Smoothly | vor 9 Tagen |
| MISC Group expands dual-fuel fleet through AET's new Suezmax contracts | vor 10 Tagen |
| MISC Orders LNG Dual-Fuel Suezmax Pair in Fleet Renewal Drive | vor 10 Tagen |
| MISC Posted 60% Jump In Q3 Profit To RM541 Million Despite Lower Revenue | vor 11 Tagen |
| MISC 3Q net profit rises 60%, declares dividend of eight sen per share | vor 11 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Omega Healthcare Investors (1 Artikel) | |
| Ocera Therapeutics (1 Artikel) | |
| Orexigen Therapeutics (2 Artikel) | |
| Orocobre (1 Artikel) | |
| Alle anzeigen | |